Dignitana AB (publ) (DIGN.ST)
SEK 0.92
(-2.65%)
SEK 0.92
(-2.65%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 86.06 Million SEK | 17.9% |
| 2022 | 72.99 Million SEK | 27.9% |
| 2021 | 57.07 Million SEK | 22.4% |
| 2020 | 46.63 Million SEK | 14.57% |
| 2019 | 40.69 Million SEK | 20.62% |
| 2018 | 33.74 Million SEK | 47.08% |
| 2017 | 22.94 Million SEK | 157.71% |
| 2016 | 8.9 Million SEK | 87.45% |
| 2015 | 4.74 Million SEK | -76.65% |
| 2014 | 20.33 Million SEK | 101.39% |
| 2013 | 10.09 Million SEK | 12.58% |
| 2012 | 8.96 Million SEK | 62.25% |
| 2011 | 5.52 Million SEK | 40.2% |
| 2010 | 3.94 Million SEK | 129.11% |
| 2009 | 1.72 Million SEK | -18.2% |
| 2008 | 2.1 Million SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 21.84 Million SEK | 3.21% |
| 2024 Q1 | 21.16 Million SEK | -0.47% |
| 2023 Q3 | 22.21 Million SEK | 5.36% |
| 2023 FY | 86.06 Million SEK | 17.9% |
| 2023 Q4 | 21.26 Million SEK | -4.29% |
| 2023 Q1 | 21.48 Million SEK | 6.14% |
| 2023 Q2 | 21.08 Million SEK | -1.86% |
| 2022 Q3 | 18.6 Million SEK | 1.74% |
| 2022 Q4 | 20.24 Million SEK | 8.83% |
| 2022 FY | 72.99 Million SEK | 27.9% |
| 2022 Q1 | 15.86 Million SEK | -2.15% |
| 2022 Q2 | 18.28 Million SEK | 15.25% |
| 2021 Q1 | 13.16 Million SEK | 1.82% |
| 2021 Q3 | 13.65 Million SEK | -2.71% |
| 2021 Q4 | 16.21 Million SEK | 18.72% |
| 2021 FY | 57.07 Million SEK | 22.4% |
| 2021 Q2 | 14.03 Million SEK | 6.63% |
| 2020 FY | 46.63 Million SEK | 14.57% |
| 2020 Q1 | 11.39 Million SEK | 19.02% |
| 2020 Q3 | 10.88 Million SEK | -4.72% |
| 2020 Q4 | 12.92 Million SEK | 18.79% |
| 2020 Q2 | 11.42 Million SEK | 0.26% |
| 2019 Q2 | 11.94 Million SEK | 29.33% |
| 2019 Q1 | 9.23 Million SEK | 6.13% |
| 2019 Q3 | 9.94 Million SEK | -16.75% |
| 2019 Q4 | 9.57 Million SEK | -3.75% |
| 2019 FY | 40.69 Million SEK | 20.62% |
| 2018 Q3 | 10.16 Million SEK | 13.26% |
| 2018 Q1 | 5.89 Million SEK | -9.35% |
| 2018 Q2 | 8.97 Million SEK | 52.22% |
| 2018 Q4 | 8.7 Million SEK | -14.39% |
| 2018 FY | 33.74 Million SEK | 47.08% |
| 2017 FY | 22.94 Million SEK | 157.71% |
| 2017 Q4 | 6.5 Million SEK | 42.96% |
| 2017 Q3 | 4.55 Million SEK | -20.99% |
| 2017 Q2 | 5.75 Million SEK | -6.01% |
| 2017 Q1 | 6.12 Million SEK | 53.11% |
| 2016 Q4 | 4 Million SEK | 42.56% |
| 2016 Q3 | 2.8 Million SEK | 193.27% |
| 2016 FY | 8.9 Million SEK | 87.45% |
| 2016 Q1 | 1.13 Million SEK | 309.66% |
| 2016 Q2 | 957.11 Thousand SEK | -15.58% |
| 2015 Q4 | 276.74 Thousand SEK | -47.72% |
| 2015 FY | 4.74 Million SEK | -76.65% |
| 2015 Q3 | 529.38 Thousand SEK | -46.01% |
| 2015 Q2 | 980.48 Thousand SEK | -66.9% |
| 2015 Q1 | 2.96 Million SEK | -67.0% |
| 2014 Q2 | 6.95 Million SEK | 621.45% |
| 2014 Q1 | 963.96 Thousand SEK | -76.93% |
| 2014 FY | 20.33 Million SEK | 101.39% |
| 2014 Q4 | 8.97 Million SEK | 161.11% |
| 2014 Q3 | 3.43 Million SEK | -50.56% |
| 2013 Q2 | 1.21 Million SEK | -68.78% |
| 2013 Q1 | 3.89 Million SEK | 505.43% |
| 2013 Q3 | 812.36 Thousand SEK | -33.14% |
| 2013 Q4 | 4.17 Million SEK | 414.34% |
| 2013 FY | 10.09 Million SEK | 12.58% |
| 2012 FY | 8.96 Million SEK | 62.25% |
| 2012 Q1 | 6.32 Million SEK | 154.75% |
| 2012 Q3 | 1.85 Million SEK | 1.21% |
| 2012 Q4 | -959.8 Thousand SEK | -151.76% |
| 2012 Q2 | 1.83 Million SEK | -71.01% |
| 2011 Q1 | 1.12 Million SEK | 1244.71% |
| 2011 Q2 | 470.46 Thousand SEK | -58.23% |
| 2011 FY | 5.52 Million SEK | 40.2% |
| 2011 Q4 | -11.54 Million SEK | -588.05% |
| 2011 Q3 | 2.36 Million SEK | 402.81% |
| 2010 Q1 | 1.13 Million SEK | 36.17% |
| 2010 Q2 | 959.25 Thousand SEK | -15.58% |
| 2010 Q4 | -98.39 Thousand SEK | -105.06% |
| 2010 Q3 | 1.94 Million SEK | 102.85% |
| 2010 FY | 3.94 Million SEK | 129.11% |
| 2009 Q4 | 834.51 Thousand SEK | 169.63% |
| 2009 Q2 | 284.15 Thousand SEK | -2.96% |
| 2009 FY | 1.72 Million SEK | -18.2% |
| 2009 Q1 | 292.82 Thousand SEK | 0.0% |
| 2009 Q3 | 309.5 Thousand SEK | 8.92% |
| 2008 FY | 2.1 Million SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acarix AB (publ) | 6.24 Million SEK | -1278.994% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | 93.732% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | 93.732% |
| Arcoma AB | 163.01 Million SEK | 47.205% |
| Bactiguard Holding AB (publ) | 203.99 Million SEK | 57.81% |
| BICO Group AB (publ) | 2.23 Billion SEK | 96.157% |
| Boule Diagnostics AB (publ) | 571.32 Million SEK | 84.936% |
| CellaVision AB (publ) | 677.29 Million SEK | 87.293% |
| Clinical Laserthermia Systems AB (publ) | 8.27 Million SEK | -940.288% |
| Chordate Medical Holding AB (publ) | 976.28 Thousand SEK | -8715.392% |
| C-Rad AB (publ) | 424.61 Million SEK | 79.732% |
| Duearity AB (publ) | 1.65 Million SEK | -5103.325% |
| Episurf Medical AB (publ) | 10.3 Million SEK | -735.563% |
| Getinge AB (publ) | 31.82 Billion SEK | 99.73% |
| Scandinavian Real Heart AB (Publ) | - SEK | -Infinity% |
| Iconovo AB (publ) | 7.07 Million SEK | -1115.873% |
| Integrum AB (publ) | 104.11 Million SEK | 17.341% |
| Luxbright AB (publ) | 854.69 Thousand SEK | -9969.393% |
| Mentice AB (publ) | 273.61 Million SEK | 68.545% |
| OssDsign AB (publ) | 112.15 Million SEK | 23.266% |
| Paxman AB (publ) | 210.11 Million SEK | 59.04% |
| Promimic AB (publ) | 37.07 Million SEK | -132.163% |
| Qlife Holding AB (publ) | 244 Thousand SEK | -35171.721% |
| SciBase Holding AB (publ) | 23.24 Million SEK | -270.243% |
| ScandiDos AB (publ) | 60.42 Million SEK | -42.42% |
| Sectra AB (publ) | 2.96 Billion SEK | 97.096% |
| Sedana Medical AB (publ) | 153.86 Million SEK | 44.067% |
| Senzime AB (publ) | 35.75 Million SEK | -140.709% |
| SpectraCure AB (publ) | 318 Thousand SEK | -26963.836% |
| Stille AB | 294.89 Million SEK | 70.816% |
| Vitrolife AB (publ) | 3.51 Billion SEK | 97.549% |
| Xvivo Perfusion AB (publ) | 597.54 Million SEK | 85.597% |